Gait in Young Children With NF1

NCT07564622 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2026-05-08

No results posted yet for this study

Summary

The objective of this study is to develop office-based tools to quantify gait in young children with NF1 that reflect overall gross motor impairment and predict future gross motor difficulties.

Conditions

  • Neurofibromatosis Type 1

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Nicolas Abreu, MD · NYU Langone Health

Eligibility

Max Age
71 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2030-01-31
Completion
2031-01-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07564622 on ClinicalTrials.gov